Bank of America’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9M | Buy |
859,423
+110,097
| +15% | +$2.54M | ﹤0.01% | 2224 |
|
|
2025
Q1 | $20.2M | Sell |
749,326
-45,435
| -6% | -$1.23M | ﹤0.01% | 2100 |
|
|
2024
Q4 | $42.6M | Buy |
794,761
+731,962
| +1,166% | +$39.2M | ﹤0.01% | 1413 |
|
|
2024
Q3 | $2.85M | Sell |
62,799
-56,596
| -47% | -$2.57M | ﹤0.01% | 3612 |
|
|
2024
Q2 | $5M | Buy |
119,395
+95,854
| +407% | +$4.02M | ﹤0.01% | 3103 |
|
|
2024
Q1 | $886K | Sell |
23,541
-20,260
| -46% | -$763K | ﹤0.01% | 4225 |
|
|
2023
Q4 | $470K | Buy |
43,801
+13,261
| +43% | +$142K | ﹤0.01% | 4665 |
|
|
2023
Q3 | $308K | Buy |
30,540
+9,393
| +44% | +$94.7K | ﹤0.01% | 4799 |
|
|
2023
Q2 | $251K | Sell |
21,147
-2,590
| -11% | -$30.7K | ﹤0.01% | 4873 |
|
|
2023
Q1 | $287K | Buy |
23,737
+5,239
| +28% | +$63.4K | ﹤0.01% | 4964 |
|
|
2022
Q4 | $244K | Buy |
18,498
+3,341
| +22% | +$44K | ﹤0.01% | 5088 |
|
|
2022
Q3 | $206K | Sell |
15,157
-10,361
| -41% | -$141K | ﹤0.01% | 5170 |
|
|
2022
Q2 | $312K | Sell |
25,518
-15,641
| -38% | -$191K | ﹤0.01% | 5040 |
|
|
2022
Q1 | $590K | Buy |
41,159
+33,525
| +439% | +$481K | ﹤0.01% | 5013 |
|
|
2021
Q4 | $150K | Buy |
7,634
+4,691
| +159% | +$92.2K | ﹤0.01% | 5842 |
|
|
2021
Q3 | $63K | Buy |
2,943
+895
| +44% | +$19.2K | ﹤0.01% | 6057 |
|
|
2021
Q2 | $52K | Buy |
+2,048
| New | +$52K | ﹤0.01% | 6010 |
|